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Effect of Sequential Therapy in H.Pylori Eradication in Comparison with 
Standard Triple Therapy 
Abstract  
Background: Helicobacter pylori is one of the most common pathogens and 
colonies in the world and its infection is an important risk factor for dangerous 
diseases such as gastric cancer. The treatment regimen that is currently used is the 
standard three-drug regimen therapy, which due to the increase in drug resistance, 
replace it with newer and more effective therapies is needed. One of these new 
therapies is sequencing therapy, which is considered as a suitable and effective 
treatment according to previous studies. The present study compares the 
effectiveness of these two treatments. 
Aim: Determining the effectiveness of sequencing therapy in eradicating 
Helicobacter pylori infection. 
Methods and materials: The present study was a descriptive-analytical study 
with the aim of retrospectively comparing the two standard three-drug therapies 
and treatment sequences in eradicating Helicobacter pylori infection in children 
referred to the Infectious Diseases Clinic of Bu Ali hospital of Ardabil university 
of medical sciences. A total of 321 people treated with sequence therapy and 410 
people with standard three-drug method and a total of 731 people were treated 
with Helicobacter pylori in 1397-98. The sample size for each method using the 
formula was 130 people for the standard three-drug method and 130 patients were 
calculated for the sequential therapy method and a total of 260 patients entered the 
study. 
Results: Two hundred and sixty patients in two groups of sequential therapy and 
standard three-drug method were included in the study. The mean age of the 
subjects in the drug sequential therapy was 7.9±3.18 years and in the standard 
three-drug method group was 7.1±2.83. There was no significant difference 
between the two groups in terms of age (P >0.05). 61.2% of the total population 
were girls and 38.8% were boys. There was no significant difference between the 
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two groups in terms of gender, history of infection in parents and season of 
treatment (P >0.05). In terms of age, the success rate in the sequential therapy 
group decreased significantly with age (P >0.05). This comparison was not 
significant for the standard method group (P >0.05). In terms of gender, the 
comparison of response to treatment in the two groups was not significant (P 
>0.05). In terms of history of parental involvement, in the sequential therapy 
group, the response rate in patients with a negative history of parental 
involvement to treatment was significantly higher (P >0.05). This comparison was 
not significant in the standard method group (P >0.05). Comparison in terms of 
adress and response to treatment was not significant in both groups (P >0.05). In 
terms of disease involvement and response to treatment, the comparison was 
significant in both groups. In both groups, the response to treatment in the first 
half of the year was higher than the last half. (P<0.05). 
Conclusion: The results of this study showed that although the sequencing 
method is a new method in the treatment of Helicobacter pylori infection, but as a 
result, the treatment is not significantly different from the standard three-drug 
method. However, the success rate of treatment in children with Helicobacter 
pylori infection was slightly higher than the standard three-drug method. 
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